Esomeprazole Magnesium Capsule, Delayed Release Pellets
Product Images NDC 0378-2350

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 0378-2350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Structural Formula (Image 01)

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Image 02)

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Image 03)

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)
The text describes the results of a study evaluating the efficacy of two doses of Esomeprazole (40 mg and 20 mg) compared to a placebo in treating patient symptoms. The data is presented in a table showing the percent of patients who were symptom-free after 14, 21, and 28 days. The table suggests that both doses of Esomeprazole led to higher percentages of symptom-free patients compared to the placebo. However, without more information about the symptoms being treated, the study design, and sample size, it is difficult to draw any further conclusions.*
FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)
The text is not available because it lacks context and meaning.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules, Usp 20 mg Bottle Label (Image 06)

Esomeprazole Magnesium Delayed-release Capsules, Usp 20 mg Bottle Label (Image 06)
The text describes a medication in the form of delayed-release capsules containing esomeprazole magnesium, USP. The capsule strength is 22.25 mg and equivalent to 20 mg of esomeprazole. The usual dosage instructions are not provided in the text. The medication should be kept out of reach of children and stored at room temperature between 20° to 26°C. It is manufactured for Mylan Pharmaceuticals Inc, located in Morgantown, WY, USA. The medication is dispensed in a container with a child-resistant closure. The text also contains various code numbers and prompt instructions related to variable data online coding that can be used for printing purposes.*
FDA Label Image

Esomeprazole Magnesium Delayed-release Capsules, Usp 40 mg Bottle Label (Image 07)

Esomeprazole Magnesium Delayed-release Capsules, Usp 40 mg Bottle Label (Image 07)
This is a prescription drug containing 40 mg of Esomeprazole magnesium in each delayed-release capsule. The medication guide should be provided to each patient. The usual dosage information is in the prescribing information. It should be stored between 20°C to 26°C (68°F to 77°F) in a tightly closed container out of the reach of children. It is manufactured for Mylan Pharmaceuticals Inc. and made in India. The product information contains a National Drug Code (NDC) 0378-2351-93 and a code number MHDRUGS/25/NKD/82. The LOT number is 1234567, and the expired date is shown as MMM.YYYY. The text also provides some additional information about dispensing and storage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.